Artialis offers biomarker-based solutions to address unmet needs for your product development in musculoskeletal disorders. From preclinical studies to postmarketing clinical trials, Artialis provides scientific expertise, R&D support services, and tools for the evaluation of clinical, structural, and biological impact of a compound on musculoskeletal health.
To bring personalized healthcare to patient and practicioner for the management of musculoskeletal diseases.
To develop solutions based on specific and innovative biomarkers in the context of precision medicine and personalized healthcare of musculoskeletal disorders.
Professionalism, dynamism, creativity, ethics.
A diversity of proactive talents working together with a complementary expertise in the evaluation of musculoskeletal disorders.